PT2855506T - Péptido e utilização do mesmo - Google Patents
Péptido e utilização do mesmoInfo
- Publication number
- PT2855506T PT2855506T PT128774437T PT12877443T PT2855506T PT 2855506 T PT2855506 T PT 2855506T PT 128774437 T PT128774437 T PT 128774437T PT 12877443 T PT12877443 T PT 12877443T PT 2855506 T PT2855506 T PT 2855506T
- Authority
- PT
- Portugal
- Prior art keywords
- peptide
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8125—Alpha-1-antitrypsin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2012/000725 WO2013173941A1 (en) | 2012-05-25 | 2012-05-25 | Peptide and the use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2855506T true PT2855506T (pt) | 2017-06-14 |
Family
ID=49622984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT128774437T PT2855506T (pt) | 2012-05-25 | 2012-05-25 | Péptido e utilização do mesmo |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US9422336B2 (pt) |
| EP (1) | EP2855506B1 (pt) |
| JP (1) | JP6097824B2 (pt) |
| KR (1) | KR101853254B1 (pt) |
| CN (1) | CN104321337B (pt) |
| AU (1) | AU2012380940B2 (pt) |
| CA (1) | CA2874258C (pt) |
| ES (1) | ES2627933T3 (pt) |
| HU (1) | HUE033389T2 (pt) |
| PL (1) | PL2855506T3 (pt) |
| PT (1) | PT2855506T (pt) |
| TW (2) | TWI570136B (pt) |
| WO (1) | WO2013173941A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI648062B (zh) * | 2015-04-16 | 2019-01-21 | 英屬維爾京群島商醫諾生藥開發有限公司 | 能夠抑制ｃ型肝炎病毒於人類脂肪幹細胞及肝細胞複製的肽及其衍生物 |
| KR20170137184A (ko) | 2015-04-16 | 2017-12-12 | 이노 바이오-드러그 디벨롭먼트 리미티드 | 인간 지방 유래 줄기 세포 및 간세포에서 c형 간염 바이러스의 복제를 저해할 수 있는 펩타이드 및 그 유도체 |
| JP6703595B2 (ja) * | 2015-04-16 | 2020-06-03 | プライム・バイオ‐ドラッグ・ディヴェロップメント・リミテッドＰｒｉｍｅ Ｂｉｏ‐Ｄｒｕｇ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | 脳血管疾患用治療ペプチド |
| KR101921468B1 (ko) * | 2018-04-24 | 2019-02-13 | 주식회사 퓨트로닉 | 모터의 퓨징 장치 |
| WO2020024142A1 (en) * | 2018-08-01 | 2020-02-06 | Vanford Bio-Drug Development Limited | Novel peptides and its derivatives capable of stimulating cytokine release |
| TWI705818B (zh) * | 2019-10-18 | 2020-10-01 | 沛爾生技醫藥股份有限公司 | 肽及其作為製備治療發炎性疾病及疼痛的藥物的用途 |
| ES2986042T3 (es) * | 2019-10-18 | 2024-11-08 | Pell Bio Med Tech Co Ltd | Péptido y su uso en la preparación de medicamentos para el tratamiento de enfermedades inflamatorias y del dolor |
| CN112759625B (zh) * | 2019-10-18 | 2023-05-05 | 沛尔生技医药股份有限公司 | 肽作为制备治疗发炎性疾病及疼痛的药物的用途 |
| WO2023184473A1 (zh) * | 2022-04-01 | 2023-10-05 | 首创生物技术有限公司 | 肽用于治疗神经退行性疾病或改善认知功能的用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53101515A (en) | 1977-02-17 | 1978-09-05 | Nippon Zoki Pharmaceutical Co | Medicine having anodyne * sedative and antiallergic activity and production thereof |
| AU2003256642B2 (en) * | 2002-07-19 | 2008-05-01 | Morphotek, Inc. | Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| CN1207005C (zh) | 2002-10-31 | 2005-06-22 | 威世药业（如皋）有限公司 | 含生物活性物质的兔皮和其用途 |
| CA2536918A1 (en) * | 2003-08-26 | 2005-03-03 | Leland Shapiro | Compositions of, and methods for, alpha-1 antitrypsin fc fusion molecules |
| WO2009005877A2 (en) * | 2007-04-20 | 2009-01-08 | Regents Of The University Of Colorado | Alpha-i antitrypsin having no significant serine protease inhibitor activity |
| CA2649261A1 (en) * | 2006-03-13 | 2007-09-20 | Keio University | Influenza infection-inhibiting peptide, influenza virus-infection inhibitor, liposome and influenza preventive/therapeutic agent |
| CN101848927B (zh) * | 2007-05-01 | 2014-10-22 | 圣保罗州支援研究基金会 | 镇痛化合物 |
| EP2330896B1 (en) * | 2008-09-10 | 2015-11-25 | Ben Gurion University Of The Negev Research And Development Authority | Antinecrotic activity of alpha 1-antitrypsin |
-
2012
- 2012-05-25 AU AU2012380940A patent/AU2012380940B2/en active Active
- 2012-05-25 CA CA2874258A patent/CA2874258C/en active Active
- 2012-05-25 WO PCT/CN2012/000725 patent/WO2013173941A1/en not_active Ceased
- 2012-05-25 KR KR1020147036227A patent/KR101853254B1/ko active Active
- 2012-05-25 ES ES12877443.7T patent/ES2627933T3/es active Active
- 2012-05-25 EP EP12877443.7A patent/EP2855506B1/en active Active
- 2012-05-25 CN CN201280071804.XA patent/CN104321337B/zh active Active
- 2012-05-25 JP JP2015512976A patent/JP6097824B2/ja active Active
- 2012-05-25 PT PT128774437T patent/PT2855506T/pt unknown
- 2012-05-25 HU HUE12877443A patent/HUE033389T2/hu unknown
- 2012-05-25 PL PL12877443T patent/PL2855506T3/pl unknown
- 2012-05-25 US US14/394,927 patent/US9422336B2/en active Active
-
2013
- 2013-05-23 TW TW102118254A patent/TWI570136B/zh active
- 2013-05-23 TW TW105102034A patent/TWI549969B/zh active
-
2016
- 2016-07-14 US US15/210,323 patent/US9839666B2/en active Active
-
2017
- 2017-03-20 US US15/463,638 patent/US20170196947A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012380940A1 (en) | 2014-12-11 |
| EP2855506A1 (en) | 2015-04-08 |
| KR101853254B1 (ko) | 2018-05-02 |
| TW201615657A (zh) | 2016-05-01 |
| HUE033389T2 (hu) | 2017-11-28 |
| US9422336B2 (en) | 2016-08-23 |
| US20170196947A1 (en) | 2017-07-13 |
| JP6097824B2 (ja) | 2017-03-15 |
| AU2012380940B2 (en) | 2016-08-25 |
| KR20150018835A (ko) | 2015-02-24 |
| JP2015519341A (ja) | 2015-07-09 |
| TWI549969B (zh) | 2016-09-21 |
| NZ702151A (en) | 2016-08-26 |
| CA2874258C (en) | 2018-08-14 |
| TWI570136B (zh) | 2017-02-11 |
| US20150218214A1 (en) | 2015-08-06 |
| US9839666B2 (en) | 2017-12-12 |
| TW201402615A (zh) | 2014-01-16 |
| PL2855506T3 (pl) | 2017-11-30 |
| CN104321337B (zh) | 2017-07-11 |
| ES2627933T3 (es) | 2017-08-01 |
| CA2874258A1 (en) | 2013-11-28 |
| US20160375092A1 (en) | 2016-12-29 |
| EP2855506B1 (en) | 2017-03-08 |
| WO2013173941A1 (en) | 2013-11-28 |
| CN104321337A (zh) | 2015-01-28 |
| EP2855506A4 (en) | 2015-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3055196T3 (en) | Anti-inflammatory peptides and composition comprising the same | |
| IL253950B (en) | Cyclic-converted uracils and their use | |
| IL236616B (en) | 5-aminotetrahydroquinoline-2-carboxylic acids and their use | |
| IL239643A0 (en) | Converted morphines and their use | |
| SG11201500111VA (en) | Peptides and uses thereof | |
| SG10201701828WA (en) | Peptides and their uses | |
| IL237135B (en) | Peptide library and their uses | |
| PT2855506T (pt) | Péptido e utilização do mesmo | |
| ZA201405392B (en) | Substituted phenylimidazopyrazoles and use thereof | |
| IL239097A0 (en) | 6-chloro-3-(phenyl-d5)-indan-1-one and its use | |
| EP2825548A4 (en) | MODIFIED KISSPEPTIN PEPTIDES AND USES THEREOF | |
| IL228995A0 (en) | b5sema peptides and components containing them | |
| IL236690A0 (en) | ube2t peptides and components containing them | |
| ZA201407276B (en) | Polypeptides and their use | |
| SG11201504482VA (en) | Beta-hexosyl-transferases and uses thereof | |
| ZA201504462B (en) | TGFß-DERIVED POLYPEPTIDES AND USES THEREOF | |
| IL237400B (en) | Rhizobacteria and its uses | |
| IL238788A0 (en) | sema5b peptides and components containing them | |
| EP2873676A4 (en) | PEPTIDE WITH LOW MOLECULAR WEIGHT AND USE THEREOF | |
| GB201214769D0 (en) | Methodsa and peptides | |
| HUE048382T2 (hu) | 6-klór-3-(fenil-d5)-inden-1-on és alkalmazása |